JavaScript is disabled for your browser. Some features of this site may not work without it.
Estadísticas
Número total de visitas
| Vistas | |
|---|---|
| Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial | 100 |
Visitas al mes
| enero 2024 | febrero 2024 | marzo 2024 | abril 2024 | mayo 2024 | junio 2024 | julio 2024 | |
|---|---|---|---|---|---|---|---|
| Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial | 10 | 3 | 3 | 3 | 6 | 6 | 2 |
Países con más visualizaciones
| Vistas |
|---|
Ciudades con más visualizaciones
| Vistas |
|---|
